메뉴 건너뛰기
Radiology
Volumn 250, Issue 2, 2009, Pages 324-326
Unresectable hepatocellular carcinoma: Serial early vascular and cellular changes after transarterial chemoembolization
Author keywords

[No Author keywords available]
Indexed keywords

ANTINEOPLASTIC AGENT; CONTRAST MEDIUM;
EID: 61749094288     PISSN: 00338419     EISSN: 15271315     Source Type: Journal    
DOI: 10.1148/radiol.2502081988     Document Type: Editorial
Times cited : (4)
References (7)
  • 1
    • 56149109078 scopus 로고    scopus 로고
    • Major trends in the imaging sciences: 2007 Eugene P. Pendergrass New Horizons Lecture
    • Zerhouni EA. Major trends in the imaging sciences: 2007 Eugene P. Pendergrass New Horizons Lecture. Radiology 2008;249(2):403-409.
    • (2008) Radiology , vol.249 , Issue.2 , pp. 403-409
    • Zerhouni, E.A.1
  • 2
    • 61749090699 scopus 로고    scopus 로고
    • Unresectable hepatocellular carcinoma: Serial early vascular and cellular changes after transarterial chemoembolization as detected with MR imaging
    • Kamel IR, Liapi E, Reyes DK, Zahurak M, Bluemke DA, Geschwind JF. Unresectable hepatocellular carcinoma: serial early vascular and cellular changes after transarterial chemoembolization as detected with MR imaging. Radiology 2009;250(2):466-473.
    • (2009) Radiology , vol.250 , Issue.2 , pp. 466-473
    • Kamel, I.R.1    Liapi, E.2    Reyes, D.K.3    Zahurak, M.4    Bluemke, D.A.5    Geschwind, J.F.6
  • 3
    • 33845402644 scopus 로고    scopus 로고
    • Transarterial therapy for hepatocellular carcinoma: Which technique is more effective? a systematic review of cohort and randomized studies
    • Marelli L, Stigliano R, Triantos C, et al. Transarterial therapy for hepatocellular carcinoma: which technique is more effective? a systematic review of cohort and randomized studies. Cardiovasc Intervent Radiol 2007;30(1):6-25.
    • (2007) Cardiovasc Intervent Radiol , vol.30 , Issue.1 , pp. 6-25
    • Marelli, L.1    Stigliano, R.2    Triantos, C.3
  • 4
    • 45849085389 scopus 로고    scopus 로고
    • Quantitative mapping of hepatic perfusion index using MR imaging: A potential reproducible tool for assessing tumour response to treatment with the antiangiogenic compound BIBF 1120, a potent triple angiokinase inhibitor
    • Miyazaki K, Collins DJ, Walker-Samuel S, et al. Quantitative mapping of hepatic perfusion index using MR imaging: a potential reproducible tool for assessing tumour response to treatment with the antiangiogenic compound BIBF 1120, a potent triple angiokinase inhibitor. Eur Radiol 2008;18(7):1414-1421.
    • (2008) Eur Radiol , vol.18 , Issue.7 , pp. 1414-1421
    • Miyazaki, K.1    Collins, D.J.2    Walker-Samuel, S.3
  • 5
    • 41849147484 scopus 로고    scopus 로고
    • Technology insight: Water diffusion MRI-a potential new biomarker of response to cancer therapy
    • Patterson DM, Padhani AR, Collins DJ. Technology insight: water diffusion MRI-a potential new biomarker of response to cancer therapy. Nat Clin Pract Oncol 2008;5(4):220-233.
    • (2008) Nat Clin Pract Oncol , vol.5 , Issue.4 , pp. 220-233
    • Patterson, D.M.1    Padhani, A.R.2    Collins, D.J.3
  • 6
    • 47949116252 scopus 로고    scopus 로고
    • Sorafenib in advanced hepatocellular carcinoma
    • Llovet JM, Ricci S, Mazzaferro V, et al. Sorafenib in advanced hepatocellular carcinoma. N Engl J Med 2008;359(4):378-390.
    • (2008) N Engl J Med , vol.359 , Issue.4 , pp. 378-390
    • Llovet, J.M.1    Ricci, S.2    Mazzaferro, V.3
  • 7
    • 33846149645 scopus 로고    scopus 로고
    • AZD2171, a pan-VEGF receptor tyrosine kinase inhibitor, normalizes tumor vasculature and alleviates edema in glioblastoma patients
    • Batchelor TT, Sorensen AG, di Tomaso E, et al. AZD2171, a pan-VEGF receptor tyrosine kinase inhibitor, normalizes tumor vasculature and alleviates edema in glioblastoma patients. Cancer Cell 2007;11(1):83-95.
    • (2007) Cancer Cell , vol.11 , Issue.1 , pp. 83-95
    • Batchelor, T.T.1    Sorensen, A.G.2    di Tomaso, E.3

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.